Conference abstract · 28 Apr 2021
Conference abstractPublished 27 Oct 2014
Analytics in biosimilar development: Comparability and similarity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In past two decades, biopharmaceutical industry has made significant foot-print in pharmaceutical industry. At present, major contributions are from innovator manufacturers. Due to patent exclusivities are reaching to their end, lot of competition is growing to manufacture these off-patent biologics. As in case of biologics, ?Process is the Product?, it becomes critically important to evaluate products manufactured by different routes. On the other hand, because of the complexity in structures and the structure?function relationship of biological therapeutics, such changes may lead to changes in molecular structures, which may adversely affect the quality, safety, or efficacy of the drug. Drug manufacturers must demonstrate the comparability of their products after process and formulation changes to ensure similar quality, safety, and efficacy. Biosimilars also require evaluation of their equivalency to the innovators' products. By complementing traditional biochemical methodologies, biophysical characterization, using a variety of methodologies, can enhance product knowledge in terms of higher order structure, molecular size distribution, and the properties of aggregates. This article presents three case studies that show the advantages of applying state-of-the-art biophysical techniques in comparability assessments.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2014
On Assessment of Analytical Similarity in Biosimilar Studies
Conference abstract · 2018
PRE-CLINICAL & CLINICAL DEVELOPMENT OF BIOSIMILAR INSULINS/INSULIN ANALOGUES: THE CLINICAL IMPLICATIONS OF CRITERIA FOR SIMILARITY
Review article · Dec 2015
Biosimilars versus originators: similarities and differences from development to approval
Conference abstract · 29 Aug 2016
New analytical methodology in assessing comparability of Biosimilars
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Alok Sharma”

